Ossdsign USA Incorporated

Reporting payments is a legal requirement; large totals often reflect large product portfolios.

$364Kgeneral payments (2019-2025)
$90Kresearch payments (2019-2025)
527clinicians paid

General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.

General payments by year

2022 $66K
2023 $100K
2024 $89K
2025 $110K

General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.

Products most associated with its payments

Specialties it works with most

Neurological Surgery $141K
Orthopaedic Surgery of The Spine $107K
Orthopaedic Surgery $97K
Foot and Ankle Surgery $6,685
Primary Podiatric Medicine $2,797
Podiatrist $2,592

Clinicians with the largest reported totals

Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.

ClinicianLocationSpecialtyGeneral payments (2019-2025)
Keneth Strenge Paducah, KY Orthopaedic Surgery of The Spine $42,687.98
Peter Whang New Haven, CT Orthopaedic Surgery $42,110.09
Jeffrey Fischgrund Southfield, MI Orthopaedic Surgery $23,106.93
Kenneth Yonemura Salt Lake City, UT Neurological Surgery $20,270.90
Brian Fiani Shelby Township, MI Neurological Surgery $20,026.30
Bernardo Ordonez Chesapeake, VA Neurological Surgery $18,458.09
Zain Boghani Gainesville, GA Neurological Surgery $17,399.04
Saeed Sadrameli Kissimmee, FL Neurological Surgery $16,329.84
Joseph Obrien Bethesda, MD Orthopaedic Surgery of The Spine $15,630.61
Fred Mo Washington, DC Orthopaedic Surgery of The Spine $15,256.79

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.